TY - JOUR
T1 - Interleukins, from 1 to 37, and interferon-γ
T2 - Receptors, functions, and roles in diseases
AU - Akdis, Mübeccel
AU - Burgler, Simone
AU - Crameri, Reto
AU - Eiwegger, Thomas
AU - Fujita, Hiroyuki
AU - Gomez, Enrique
AU - Klunker, Sven
AU - Meyer, Norbert
AU - O'Mahony, Liam
AU - Palomares, Oscar
AU - Rhyner, Claudio
AU - Quaked, Nadia
AU - Schaffartzik, Anna
AU - Van De Veen, Willem
AU - Zeller, Sabine
AU - Zimmermann, Maya
AU - Akdis, Cezmi A.
PY - 2011/3
Y1 - 2011/3
N2 - Advancing our understanding of mechanisms of immune regulation in allergy, asthma, autoimmune diseases, tumor development, organ transplantation, and chronic infections could lead to effective and targeted therapies. Subsets of immune and inflammatory cells interact via ILs and IFNs; reciprocal regulation and counter balance among Th and regulatory T cells, as well as subsets of B cells, offer opportunities for immune interventions. Here, we review current knowledge about ILs 1 to 37 and IFN-γ. Our understanding of the effects of ILs has greatly increased since the discoveries of monocyte IL (called IL-1) and lymphocyte IL (called IL-2); more than 40 cytokines are now designated as ILs. Studies of transgenic or knockout mice with altered expression of these cytokines or their receptors and analyses of mutations and polymorphisms in human genes that encode these products have provided important information about IL and IFN functions. We discuss their signaling pathways, cellular sources, targets, roles in immune regulation and cellular networks, roles in allergy and asthma, and roles in defense against infections.
AB - Advancing our understanding of mechanisms of immune regulation in allergy, asthma, autoimmune diseases, tumor development, organ transplantation, and chronic infections could lead to effective and targeted therapies. Subsets of immune and inflammatory cells interact via ILs and IFNs; reciprocal regulation and counter balance among Th and regulatory T cells, as well as subsets of B cells, offer opportunities for immune interventions. Here, we review current knowledge about ILs 1 to 37 and IFN-γ. Our understanding of the effects of ILs has greatly increased since the discoveries of monocyte IL (called IL-1) and lymphocyte IL (called IL-2); more than 40 cytokines are now designated as ILs. Studies of transgenic or knockout mice with altered expression of these cytokines or their receptors and analyses of mutations and polymorphisms in human genes that encode these products have provided important information about IL and IFN functions. We discuss their signaling pathways, cellular sources, targets, roles in immune regulation and cellular networks, roles in allergy and asthma, and roles in defense against infections.
KW - adaptive immune response
KW - allergy and asthma
KW - B cells
KW - Cytokines
KW - dendritic cells
KW - humoral immune response
KW - interleukins
KW - T cells
UR - http://www.scopus.com/inward/record.url?scp=79952291528&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2010.11.050
DO - 10.1016/j.jaci.2010.11.050
M3 - Journal article
AN - SCOPUS:79952291528
SN - 0091-6749
VL - 127
SP - 701-721.e70
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3
ER -